Related Experiment Video
Updated: Jun 8, 2026
04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
The association between multinodular goiter and thyroid cancer
1University of Würzburg, Department of Nuclear Medicine, Würzburg, Germany. verburg_e@klinik.uni-wuerzburg.de
Minerva Endocrinologica
|October 13, 2010
Summary
Multinodular goiter, common in iodine-deficient areas, complicates differentiated thyroid cancer diagnosis and treatment. Research explores links between multinodular goiter and thyroid cancer, aiming to prevent its development.
Area of Science:
- Endocrinology
- Oncology
- Public Health
Background:
- Multinodular goiter (MNG) remains endemic globally, particularly in regions with historical or current iodine deficiency.
- A complex interplay exists between the underlying causes of MNG and the development of differentiated thyroid cancer (DTC).
Purpose of the Study:
- To review clinically significant aspects of the association between MNG and DTC.
- To discuss diagnostic and therapeutic challenges posed by MNG in DTC patients.
- To explore potential strategies for preventing thyroid cancer development in individuals with MNG.
Main Methods:
- This is a review article, synthesizing existing clinical and etiological data.
- The review focuses on the association between MNG and DTC, drawing from relevant literature.
Main Results:
- Intriguing etiological links between MNG and DTC are identified.
- MNG presents significant diagnostic challenges for DTC detection.
- MNG complicates the treatment of DTC patients.
Conclusions:
- Understanding the shared etiologies may offer insights into DTC incidence in MNG.
- Addressing diagnostic and therapeutic hurdles in MNG patients is crucial for effective DTC management.
- Further research into preventative measures against thyroid cancer in MNG is warranted.
Related Concept Videos
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...